Philadelphia Phillies3vs.Atlanta Braves won5

MLBFinal24h volume $1.2M

Market price

Sep 28 forecast

Sale’s dominance of Philadelphia is offset by his postseason record and Atlanta’s injuries.

Atlanta has the cleaner starting-pitcher case: Sale excelled against Philadelphia, while Philadelphia’s offense and bullpen struggled in September. The counterweight is Sale’s poor postseason record and Atlanta’s reduced roster depth. Philadelphia is slightly more likely to win, but Sale can dominate this matchup and keep the opener close.

Points to NO

Sale’s postseason history raises the risk that his regular-season form will not carry over.
Entering the 2026 Wild Card Series on September 28, Sale had a 7.24 ERA across seven postseason starts.
Lane Thomas’s expected absence narrows Atlanta’s position-player options.
On September 28, MLB.com assessed that Thomas likely would not be ready for the Wild Card Series.

Points to YES

Sale enters with an exceptional recent record against Philadelphia.
Through September 27, Sale was 3-0 with a 2.08 ERA in four 2026 starts against Philadelphia.
Philadelphia’s September offensive slump makes Sale’s matchup more favorable.
At the end of the regular season on September 27, Philadelphia ranked 29th in MLB with a .660 September OPS.
Philadelphia’s struggling bullpen leaves it vulnerable if the game remains close after the starters exit.
Through September 27, Philadelphia relievers had an MLB-worst 5.79 ERA in September.

Research and information only. Not financial advice or a recommendation to trade. Markets involve risk, including loss of capital. Review venue rules and eligibility before trading.